(ShareCast News) - Stocks have started the session slightly higher, with analysts' focus initially on oil and trade, with the former pushing further past the three-year highs notched up during the previous session.
(ShareCast News) - Beleaguered mother and child retailer Mothercare announced the departure of chairman Alan Parker on Thursday, hot on the heels of the appointment of a new chief executive earlier this month.
(ShareCast News) - Telecom Plus, which trades as the Utility Warehouse, said on Thursday that full-year adjusted pre-tax profits from continuing operations are expected to have risen, as customer numbers increased.
(ShareCast News) - Clinical stage biotechnology company ValiRx has seen positive results from recent studies into the effectiveness of its VAL101 compound's ability to induce cancer cells to kill themselves off.
(ShareCast News) - GlaxoSmithKline, alongside Nasdaq-listed partner Innoviva, announced the publication of the landmark IMPACT study - one of the biggest ever conducted in patients with chronic obstructive pulmonary disease with a history of exacerbation - in the New England Journal of Medicine on T...
(ShareCast News) - Clinical stage stem cell business ReNeuron Group has won a £1.5m grant to advance development of its hRPC stem cell therapy candidate for blindness-causing degenerative diseases of the retina.
(ShareCast News) - BHP Billiton posted its operational review for the nine months ended 31 March on Thursday, confirming that its full-year production guidance remained unchanged for petroleum, metallurgical coal and energy coal.
(ShareCast News) - Debenhams profits plunged 85% in the first half of its financial year as like-for-like sales slipped amid the "challenging UK market background" and heavy snow, while finance director jumped ship to join a department store rival.
(ShareCast News) - Essentra, a FTSE 250 supplier of plastic and fibre products, said on Thursday that trading in the financial year-to-date has been in line with the board's expectations, as it announced the departure of its group finance director.
(ShareCast News) - AstraZeneca announced on Thursday that the US Food and Drug Administration has approved Tagrisso (osimertinib) for the first-line treatment of patients with metastatic non-small cell lung cancer, whose tumours have epidermal growth factor receptor mutations as detected by an FDA-a...
(ShareCast News) - Broadcaster Sky, which is currently the subject of a bidding war, posted a 5% jump in nine-month like-for-like revenues on Thursday as core earnings rose 14%, and the company said it remains on track for the full year.
(ShareCast News) - Unilever sales growth slowed in the first quarter, but solid volume growth gave the consumer goods colossus confidence of hitting its full-year sales and margin targets in spite of flat prices.
(ShareCast News) - Pest control group Rentokil Initial's underlying revenue growth slowed in the first quarter because of the impact of the hurricane in Puerto Rico and cold weather in the US that delayed the emergence of spring pests.
It is important to remember that the value of investments can go down as well as up and it is possible to get back less than you invested, especially in the early years. Past performance is no guarantee of future returns and interest rates and dividends are variable and cannot be guaranteed in the future. Any tax treatment mentioned is based on personal circumstances and current legislation which is subject to change. In the event of a client having a complaint about our services we will do our best to resolve that complaint promptly and to the client's satisfaction. However if we are unable to do so, the client may have the right to complain to the Financial Ombudsman Service. Further information can be found on the Financial Ombudsman Services's Website at www.financial-ombudsman.org.uk.